Category Archives: Europe

UK Reacts to AZ Job Cuts

UK Waits for AZ Job Cut Breakdown As this blog was posted, AstraZeneca was still keeping the world in suspense as to a further breakdown of its announced 7,300 job cuts. The company’s UK staff assembled for a meeting at 10 am, but as of lunchtime there was still no confirmation of the actual numbers , [...]
Posted in Europe | Tagged , , , | Leave a comment

Roche Ups the Stakes on Personalized Medicine

By Patricia Van Arnum, Pharmaceutical Technology. Personalized medicine, which targets individualized treatment and care based on personal and genetic variations, holds much promise for the pharmaceutical industry. Several pharmaceutical majors continue to invest in this emerging field as evident by Roche’s $5.7-billion bid last week for Illumina, a provider of gene-sequencing tools and related analytics.
Also posted in Biotech, Global, Guest Blog | Tagged , , | Leave a comment

GSK's Andrew Witty: Further Concerns for Europe

GSK’s Andrew Witty underlined his growing concerns with the business climate in Europe with his comments to the UK’s High Pay Commission last week. The Commission, set up by left-wing pressure group Compass, reported on the ‘corrosive’ effects of ‘boardroom excess’ and called for greater transparency in the setting of executive pay. The pay of [...]
Also posted in Global, People, pricing | Tagged , , , , , | Leave a comment

Election Landslide: What Now for Spanish Healthcare?

The fact that the eurozone is in a tailspin is hardly ‘news’, but when heads start rolling as fast as they have done recently in Greece, Italy, and now Spain, it leaves the unsettling feeling that the heat on an already intense situation has been turned up one more notch.
Also posted in healthcare | Tagged , , , , | 1 Comment

European Pharma 1981-2011: Survival of the Fittest?

This month sees Pharmaceutical Executive magazine reach its 30th birthday. In line with that milestone, Reflector assesses what the last three decades have meant for European pharma — and shows how the game has changed beyond recognition. Thirty years is a long time in any industry. The coalmining industry, the market for air travel, or telecommunications [...]
Also posted in Emerging Markets, Global, Guest Blog, IP, Pharm Exec Magazine, R&D, Regulatory, healthcare, leadership | Tagged , , , , , , | Leave a comment